Innovations In Clinical Practice: Managing Medetomidine Intoxication and Withdrawal in Philadelphia

AVAILABLE ON-DEMAND

Available on-demand. Login or create an account to register to view the recording.

Description

In late 2024, clinicians in Philadelphia witnessed a dramatic change in the street drug supply: medetomidine, an alpha-2-agonist used as a veterinary sedative, had replaced xylazine as the most common additive in fentanyl drug samples. This lecture explores the emergence of this new drug trend and how to manage this life-threatening withdrawal syndrome.

Learning Objectives

At the conclusion of this presentation, participants should be able to:

Summarize the emergence of medetomidine in the Philadelphia street drug supply.
Describe the presentation of medetomidine-exposed patients from intoxication to withdrawal phase.
Select appropriate pharmacologic agents to treat alpha-2 withdrawal.

Claim Credit & Course Material

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):

Complete the required course materials.
Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.

Credit Statement

This webinar has been approved for a maximum 1, AOA Category 1-A CME credits. Physicians should claim only the credit commensurate with the extent of their participation. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA) and AOAAM. The AOAAM is accredited by the AOA to provide continuing medical education for physicians.

Speaker

TaReva Warrick-Stone, DO

TaReva Warrick-Stone, DO is a Clinical Assistant Professor at Thomas Jefferson University Hospital in Philadelphia, PA. Board certified in Family Medicine, Emergency Medicine, and Addiction Medicine, she graduated from Jefferson Northeast's dual residency in 2023 and completed fellowship at Thomas Jefferson University in 2024. Her clinical work in addiction medicine spans both inpatient and outpatient settings, with a focus on improved quality of care through withdrawal protocols for the acute care setting, hospital consults to engage a multidisciplinary addiction medicine team, and low barrier bridge clinic access to medications for opioid use disorder. Her research interests include HIV and Hepatitis C and B care (screening, treatment, and prevention) in patients who use substances and examining the impact of inpatient addiction medicine consult services and withdrawal management protocols.

Summary

Availability:

On-Demand

Access expires on Nov 01, 2028

Cost:

Member: $0.00
Non-Member: $35.00
Resident/Intern Member: $0.00
Student Member: $0.00

Credit Offered:

1 AOA Category 1A Credit

Create Account